vs
Side-by-side financial comparison of BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
BRIGHT HORIZONS FAMILY SOLUTIONS INC. is the larger business by last-quarter revenue ($733.7M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). On growth, BRIGHT HORIZONS FAMILY SOLUTIONS INC. posted the faster year-over-year revenue change (8.8% vs -1.7%). Over the past eight quarters, BRIGHT HORIZONS FAMILY SOLUTIONS INC.'s revenue compounded faster (8.5% CAGR vs -0.1%).
Bright Horizons Family Solutions Inc. is a United States–based child-care provider and is the largest provider of employer-sponsored child care. It also provides back-up child care and elder care, tuition program management, education advising, and student loan repayment programs. It is headquartered in Newton, Massachusetts.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BFAM vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $733.7M | $493.8M |
| Net Profit | — | $33.7M |
| Gross Margin | 19.3% | — |
| Operating Margin | 6.2% | 9.9% |
| Net Margin | — | 6.8% |
| Revenue YoY | 8.8% | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | $0.38 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $733.7M | $493.8M | ||
| Q3 25 | $802.8M | $492.9M | ||
| Q2 25 | $731.6M | $468.8M | ||
| Q1 25 | $665.5M | $458.4M | ||
| Q4 24 | $674.1M | $502.4M | ||
| Q3 24 | $719.1M | $511.2M | ||
| Q2 24 | $670.1M | $504.3M | ||
| Q1 24 | $622.7M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $78.6M | $71.7M | ||
| Q2 25 | $54.8M | $39.3M | ||
| Q1 25 | $38.0M | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $54.9M | $19.4M | ||
| Q2 24 | $39.2M | $-153.0M | ||
| Q1 24 | $17.0M | $4.0M |
| Q4 25 | 19.3% | — | ||
| Q3 25 | 27.0% | — | ||
| Q2 25 | 25.0% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | 24.2% | — | ||
| Q1 24 | 21.7% | — |
| Q4 25 | 6.2% | 9.9% | ||
| Q3 25 | 15.1% | 13.8% | ||
| Q2 25 | 11.8% | 12.8% | ||
| Q1 25 | 9.4% | 7.0% | ||
| Q4 24 | 7.2% | 7.8% | ||
| Q3 24 | 12.4% | 6.6% | ||
| Q2 24 | 10.3% | -31.3% | ||
| Q1 24 | 6.4% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 9.8% | 14.5% | ||
| Q2 25 | 7.5% | 8.4% | ||
| Q1 25 | 5.7% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 7.6% | 3.8% | ||
| Q2 24 | 5.8% | -30.3% | ||
| Q1 24 | 2.7% | 0.8% |
| Q4 25 | $0.38 | $0.40 | ||
| Q3 25 | $1.37 | $0.84 | ||
| Q2 25 | $0.95 | $0.46 | ||
| Q1 25 | $0.66 | $0.24 | ||
| Q4 24 | $0.50 | $0.37 | ||
| Q3 24 | $0.94 | $0.23 | ||
| Q2 24 | $0.67 | $-1.84 | ||
| Q1 24 | $0.29 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $140.1M | $375.2M |
| Total DebtLower is stronger | $747.6M | $570.5M |
| Stockholders' EquityBook value | $1.3B | $865.9M |
| Total Assets | $3.9B | $2.2B |
| Debt / EquityLower = less leverage | 0.56× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $140.1M | $375.2M | ||
| Q3 25 | $116.6M | $340.1M | ||
| Q2 25 | $179.2M | $224.7M | ||
| Q1 25 | $112.0M | $99.0M | ||
| Q4 24 | $110.3M | $229.9M | ||
| Q3 24 | $109.9M | $103.8M | ||
| Q2 24 | $140.2M | $19.4M | ||
| Q1 24 | $63.7M | $8.0M |
| Q4 25 | $747.6M | $570.5M | ||
| Q3 25 | $747.5M | $577.2M | ||
| Q2 25 | $797.0M | $583.9M | ||
| Q1 25 | $872.7M | $590.5M | ||
| Q4 24 | $918.4M | $597.1M | ||
| Q3 24 | $925.7M | — | ||
| Q2 24 | $931.9M | — | ||
| Q1 24 | $938.1M | — |
| Q4 25 | $1.3B | $865.9M | ||
| Q3 25 | $1.4B | $890.7M | ||
| Q2 25 | $1.4B | $833.8M | ||
| Q1 25 | $1.3B | $789.2M | ||
| Q4 24 | $1.3B | $764.9M | ||
| Q3 24 | $1.4B | $732.5M | ||
| Q2 24 | $1.3B | $706.5M | ||
| Q1 24 | $1.2B | $856.2M |
| Q4 25 | $3.9B | $2.2B | ||
| Q3 25 | $3.9B | $2.2B | ||
| Q2 25 | $3.9B | $2.1B | ||
| Q1 25 | $3.8B | $2.0B | ||
| Q4 24 | $3.9B | $2.2B | ||
| Q3 24 | $3.9B | $2.1B | ||
| Q2 24 | $3.8B | $2.0B | ||
| Q1 24 | $3.8B | $2.2B |
| Q4 25 | 0.56× | 0.66× | ||
| Q3 25 | 0.52× | 0.65× | ||
| Q2 25 | 0.57× | 0.70× | ||
| Q1 25 | 0.66× | 0.75× | ||
| Q4 24 | 0.72× | 0.78× | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 0.73× | — | ||
| Q1 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $350.7M | $114.1M |
| Free Cash FlowOCF − Capex | $258.5M | — |
| FCF MarginFCF / Revenue | 35.2% | — |
| Capex IntensityCapex / Revenue | 12.6% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $402.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $350.7M | $114.1M | ||
| Q3 25 | $-17.6M | $137.3M | ||
| Q2 25 | $134.2M | $137.2M | ||
| Q1 25 | $86.2M | $-117.5M | ||
| Q4 24 | $337.5M | $133.0M | ||
| Q3 24 | $-8.9M | $91.8M | ||
| Q2 24 | $109.4M | $107.0M | ||
| Q1 24 | $116.3M | $-125.2M |
| Q4 25 | $258.5M | — | ||
| Q3 25 | $-42.4M | — | ||
| Q2 25 | $115.4M | — | ||
| Q1 25 | $70.9M | — | ||
| Q4 24 | $240.2M | — | ||
| Q3 24 | $-32.2M | — | ||
| Q2 24 | $86.8M | — | ||
| Q1 24 | $96.9M | — |
| Q4 25 | 35.2% | — | ||
| Q3 25 | -5.3% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 35.6% | — | ||
| Q3 24 | -4.5% | — | ||
| Q2 24 | 13.0% | — | ||
| Q1 24 | 15.6% | — |
| Q4 25 | 12.6% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 3.1% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | -0.22× | 1.91× | ||
| Q2 25 | 2.45× | 3.49× | ||
| Q1 25 | 2.26× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | -0.16× | 4.72× | ||
| Q2 24 | 2.79× | — | ||
| Q1 24 | 6.85× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFAM
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
